Jaguar Health, Inc.
JAGX
$0.32
-$0.05-13.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 10.45% | 14.12% | -38.82% | -6.76% | -13.96% |
| Total Depreciation and Amortization | -5.63% | -5.14% | -6.62% | -4.41% | -3.94% |
| Total Amortization of Deferred Charges | -- | -- | -44.16% | -100.00% | -100.00% |
| Total Other Non-Cash Items | 21.82% | 11.61% | 14.74% | 1.90% | 104.28% |
| Change in Net Operating Assets | 4,316.00% | 1,001.50% | 648.47% | 152.01% | 103.15% |
| Cash from Operations | 75.85% | 74.56% | 19.39% | 10.29% | 6.05% |
| Capital Expenditure | -- | -156.25% | -156.25% | -237.50% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 80.93% | 82.25% | 82.25% | -1,581.25% | -1,243.75% |
| Total Debt Issued | 190.28% | 189.94% | -- | -- | -- |
| Total Debt Repaid | -816.39% | -859.81% | -6.21% | 34.35% | 16.31% |
| Issuance of Common Stock | -63.22% | -67.02% | -72.55% | -69.75% | -68.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 158.95% | -133.33% | 7.64% | -118.19% | -109.06% |
| Cash from Financing | -19.20% | -49.42% | -24.14% | -57.18% | -62.11% |
| Foreign Exchange rate Adjustments | -375.00% | -13,300.00% | -109.26% | -445.65% | 1,460.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 131.66% | 173.13% | -111.09% | -197.00% | -286.50% |